Loading...

Supernus Pharmaceuticals, Inc.

0LB2.L•LSE
Healthcare
Medical - Pharmaceuticals
£45.00
£2.00(4.65%)

Supernus Pharmaceuticals, Inc. (0LB2.L) Stock Chart & Performance Analysis

Explore Supernus Pharmaceuticals, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-5.52%
5-Day Change
-1.24%
1-Month Change
-3.47%
3-Month Change
-19.95%
6-Month Change
-8.46%
Year-to-Date (YTD) Change
-16.60%
1-Year Change
-6.80%
3-Year Change
-7.57%
5-Year Change
24.19%
All-Time (Max) Change
-26.92%

Analyzing Supernus Pharmaceuticals, Inc. (0LB2.L) Trends Across Multiple Time Frames

Supernus Pharmaceuticals, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Supernus Pharmaceuticals, Inc. stock shows -5.52% 1-day change, indicating low volatility, while its 5-day change of -1.24% suggests a broader trend. Over a 1-month period, a -3.47% drop could signal a pullback, whereas a 3-month decline of -19.95% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -8.46% and a YTD drop of -16.60% might concern investors, but a 1-year loss of -6.80% and a 3-year drop of -7.57% could indicate resilience. The 5-year surge of 24.19% highlights strong historical growth, while the all-time return of -26.92% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;